1994 | |
1994_1_A: |
Journal of Medical Screening |
1994_1_B: |
Screening for malignant melanoma |
1994_2_A: |
Medical screening: the way forward |
1994_3_A: |
Screening for neuroblastoma in children |
1994_3_B: |
Why screen for HIV infection in pregnancy? |
1994_4_A: |
What are we screening for? |
1994_4_B: |
Is screening for ovarian cancer worthwhile? |
1994_4_C: |
"Opportunistic" screening |
1995 | |
1995_1_A: |
The risk figure of 1/270 |
1995_1_B: |
Information leaflets |
1995_2_A: |
The health service and personal costs of screening |
1995_4_A: |
Breast screening in Britain |
1996 | |
1996_1_A: |
What is case-finding? |
1996_1_B: |
Should testicular self examination be recommended? |
1996_2_A: |
What is genetic screening anyway? |
1996_4_A: |
Prevention of blindness: a lost opportunity |
1996_4_B: |
Screening for haemochromatosis |
1997 | |
1997_1_A: |
Why the term "carrier screening" should be abandoned |
1997_1_B: |
Epidemiological clues from screening |
1997_2_A: |
Case-control studies of the efficacy of screening for cancer: can we earn them some respect? |
1997_2_B: |
Screening for Huntington disease and certain other dominantly inherited disorders: a case for preimplantation genetic testing |
1997_2_C: |
Systematic reviews of screening |
1997_3_A: |
Screening for neuroblastoma in children |
1997_4_A: |
National Institutes of Health consensus development conference statement on genetic testing for cystic fibrosis |
1998 | |
1998_1_A: |
Should we screen for factor V Leiden? |
1998_1_B: |
Down's syndrome screening in twins |
1998_1_C: |
Voluntary registration of unreported randomised trials: an initiative from medical editors |
1998_3_A: |
Current state of second trimester screening for Down's syndrome |
1998_4_A: |
The first report of the National Screening Committee |
1998_4_B: |
Antenatal screening for HIV in the UK: what is to be done? |
1999 | |
1999_1_A: |
Prenatal cytogenetic diagnosis |
1999_2_A: |
Cervical screening programme, England: 1997-98 |
1999_3_A: |
Reporting of screening results |
1999_4_A: |
Preventing neural tube defects: a major success story, with a chapter yet to be written |
2000 | |
2000_1_A: |
Populist instead of professional |
2000_1_B: |
Screening for hypothyroidism in adults: supporting data from two population studies |
2000_1_C: |
Screening for type II diabetes mellitus |
2000_1_D: |
The challenge of preventive medicine in 2000 |
2000_2_A: |
When screening is not enough |
2000_3_A: |
Spiral computed tomography screening |
2000_3_B: |
In search of better ways to transmit information about screening tests |
2001 | |
2001_1_A: |
The definition of screening |
2001_2_A: |
Screening newborn infants for cystic fibrosis |
2001_2_B: |
The threat to the use of records and stored blood samples in medical screening research |
2001_2_C: |
Consenting adults |
2001_3_A: |
JMS Online at a screen near you: www.jmedscreen.com |
2001_3_B: |
The number needed to screen - an adaptation of the number needed to treat |
2001_4_A: |
All screening is universal |
2002 | |
2002_1_A: |
The Medical Screening Society |
2002_2_A: |
Could HPV testing become the sole primary cervical screening test? |
2002_2_B: |
Outcome events in studies of diagnostic or screening tests |
2002_2_C: |
Faecal occult blood screening for colorectal cancer |
2002_2_D: |
Screening for neuroblastoma in children |
2002_3_A: |
The National Down Syndrome Cytogenetic Register (NDSCR) |
2002_4_A: |
Seeking other disorders within antenatal serum screening programmes for Down's syndrome |
2003 | |
2003_1_A: |
Under new management! Medical Screening Society buys Journal of Medical Screening |
2003_2_A: |
Safety First: choices in antenatal screening for Down's syndrome |
2003_3_A: |
Prenatal screening for cystic fibrosis in the United States - time to re-evaluate implementation policies |
2003_4_A: |
How frequently should cervical screening be conducted - important new evidence |
2004 | |
2004_1_A: |
Live long and prosper: a mass strategy for treating the factors associated with ischaemic heart disease and stroke |
2004_2_A: |
NHS breast screening: the progression from one to two views |
2004_2_B: |
Is cascade testing a sensible method of population screening? |
2004_4_A: |
The vagaries of prostate cancer screening |
2005 | |
2005_1_A: |
An epidemic averted through medical screening |
2005_2_A: |
Couple screening to avoid thalassemia: successful in Iran and instructive for us all |
2005_2_B: |
Screening, surgical repair, and the management of abdominal aortic aneurisms |
2005_2_C: |
Medical screening society working groups |
2005_3_A: |
Screening for oesophageal cancer: is it timely or premature? |
2005_4_A: |
Prophylactic vaccines for human papillomavirus: a bright future for cervical cancer prevention |
2006 | |
2006_1_A: |
Screening for chronic glaucoma |
2006_2_A: |
When screening is still not enough |
2006_2_B: |
Our health, our care, our say |
2006_2_C: |
NHS breast screening: a model national programme |
2006_3_A: |
Information leaflets in medical screening |
2007 | |
2007_1_A: |
Paying for publication |
2007_4_A: |
Screening: a step too far. A matter of concern |
2009 | |
2009_3_A: |
What now on screening for prostate cancer? |
2010 | |
2010_2_A: |
ACOG guidelines on cervical screening: a step in the right direction |
2010_2_B: |
Colorectal cancer prevention through screening: population acceptance of flexible sigmoidoscopy |
2010_4_A: |
Hypothyroidism: detecting and treating early symptoms as the body's energy rheostat is slowly turned down |
2011 | |
2011_1_A: |
Discounting the value of life |
2011_2_A: |
Genetic testing |
2011_2_B: |
Genetic profiling tests in screening for cardiovascular disease |
2011_2_C: |
Vitamin D and rickets: much has been accomplished, but there is room for improvement |
2011_3_A: |
Lung cancer screening with low-dose helical CT: results from the National Lung Screening Trial (NLST) |
2011_3_B: |
Some clarity in the management of DCIS in breast cancer screening |
2011_4_A: |
Estimates of the potential risk of radiation-related cancerfrom screening in the UK |
2011_4_B: |
Screening for cardiovascular disease: concerns with a Norwegian proposal |
2011_4_C: |
Screening to detect Lynch syndrome and prevent hereditary cancers in relatives |
2012 | |
2012_2_A: |
Colonoscopy as a primary screening method? |
2012_2_B: |
Maternal plasma DNA: a major step forward in prenatal testing |
2012_3.1_A: |
The benefits and harms of mammographic screening for breast cancer: building the evidence base using service screening programmes |
2012_4_A: |
The Canadian recommendations on screening for type 2 diabetes |
2013 | |
2013_2_A: |
The press, press releases, and raising unwarranted expectations |
2014 | |
2014_1_A: |
Cochrane report on lowering blood pressure |
2014_2_A: |
Recent results from the two Canadian Breast Screening Trials |
2015 | |
2015_3_A: |
Screening for breast cancer by molecular testing for three founder mutations in the BRCA1 and BRCA2 genes among women of Ashkenazi Jewish heritage |
2015_4_A: |
Informed decision-making and breast cancer screening |
2016 | |
2016_2_A: |
The NHS Health Checks programme: A better alternative |
2016_3_A: |
Discounting financial costs and health benefits in public health programmes |
2017 | |
2017_2_A: |
Sharing clinical trial data |
2017_4_A: |
Screening and preventive medication |
2018 | |
2018_3_A: |
Medical Screening Society members' talks |
2019 | |
2019_1_A: |
Conflating screening detection rates with the uptake of further testing: A potential source of confusion |
2019_2_A: |
Risk stratification in breast screening: A word of caution |
2020 | |
2020_2_A: |
Flexible use of flexible sigmoidoscopy |
2021 | |
2021_1_A: |
NHS announces a pilot of a blood test for early detection of many cancers |